Company Filing History:
Years Active: 2020-2022
Title: Emily Lindemer: Innovator in Patient Complexity Classification
Introduction
Emily Lindemer is a notable inventor based in Allston, MA (US). She has made significant contributions to the field of artificial intelligence in healthcare, particularly through her innovative patents. With a total of two patents to her name, Lindemer is recognized for her work in enhancing patient evaluation processes.
Latest Patents
Lindemer's latest patents focus on an Automated Patient Complexity Classification (PCC) system for artificial intelligence tools. This system is designed to receive medical image study data, which includes various medical image data structures and corresponding metadata. A natural language processing engine within the PCC system extracts features indicative of patient or medical image characteristics. The complexity classifier then evaluates these features to determine a patient complexity score, which reflects the complexity of the patient's medical condition. The system also includes routing logic that directs the medical image data and metadata to downstream patient evaluation systems based on the determined complexity.
Career Highlights
Emily Lindemer is currently employed at International Business Machines Corporation (IBM), where she continues to develop innovative solutions in the healthcare sector. Her work is instrumental in bridging the gap between technology and patient care, making significant strides in the use of artificial intelligence for medical evaluations.
Collaborations
Lindemer collaborates with talented individuals such as David Joseph Richmond and Marwan Sati. These partnerships enhance her research and development efforts, contributing to the advancement of her projects.
Conclusion
Emily Lindemer is a pioneering inventor whose work in patient complexity classification is transforming the healthcare landscape. Her contributions through innovative patents are paving the way for more efficient patient evaluations and improved medical outcomes.